Ticker
PHATCompany Name
PHATHOM PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Debt | Shareholders Equity | Invested Capital |
---|---|---|---|
6/30/2025 | $ 552.97M | $ -405.83M | $ 147.13M |
3/31/2025 | $ 547.37M | $ -338.38M | $ 208.99M |
12/31/2024 | $ 535.17M | $ -253.58M | $ 281.59M |
9/30/2024 | $ 498.8M | $ -187.11M | $ 311.69M |
6/30/2024 | $ 496.47M | $ -233.83M | $ 262.64M |
3/31/2024 | $ 452.57M | $ -148.5M | $ 304.07M |
12/31/2023 | $ 438.85M | $ -72.76M | $ 366.09M |
9/30/2023 | $ 224.01M | $ -17.77M | $ 206.23M |
6/30/2023 | $ 219.11M | $ 17.6M | $ 236.71M |
3/31/2023 | $ 212.97M | $ -90.19M | $ 122.78M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt + Equity
(=) Inv. Capital
Inv. Capital for PHATHOM PHARMACEUTICALS INC is calculated as follows: Debt [ $ 48.69M ] + Equity [ $ 156.39M ]
(=) Inv. Capital [ $ 205.08M ]
Minimum
Mar 31, 2023
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.44K |
---|---|
min | $ -1.51B |
max | $ 4.11B |
average | $ 759.87M |
median | $ 302.55M |
std | $ 1B |